Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Safety and Efficacy of Cariprazine in Patients With Schizophrenia

ClinicalTrials.gov ID: NCT01104766

Public ClinicalTrials.gov record NCT01104766. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 11, 2026, 9:18 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-Blind, Placebo and Active-Controlled Evaluation of the Safety and Efficacy of Cariprazine in the Acute Exacerbation of Schizophrenia

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The objective of this study is to evaluate the efficacy, safety, and tolerability of cariprazine relative to placebo for the treatment of acute exacerbation of schizophrenia.

Study identification

NCT ID
NCT01104766
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Forest Laboratories
Industry
Enrollment
617 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 60 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 23, 2010 (Actual)
Primary completion
Dec 20, 2011 (Actual)
Completion
Dec 20, 2011 (Actual)
Last update posted
Oct 29, 2018

2010 – 2011

United States locations

U.S. sites
20
U.S. states
14
U.S. cities
20
Facility City State ZIP Site status
Woodland International Research Group, Inc. Little Rock Arkansas 72211 —
Woodland Research Northwest, LLC Springdale Arkansas 72764 —
Synergy Clinical Research of Escondido Escondido California 92025 —
Excell Research, Inc Oceanside California 92056 —
Clinical Innovations, Inc. Riverside California 92506 —
Sharp Mesa Vista Hospital San Diego California 92123 —
Collaborative Neuroscience Network, Inc. Torrance California 90502 —
Colorado Clinical Trials, Inc. Littleton Colorado 80130 —
Comprehensive Clinical Development, Inc. Washington D.C. District of Columbia 20016 —
Florida Clinical Research Center, LLC Bradenton Florida 34208 —
Hawaii Clinical Research Center Honolulu Hawaii 96813 —
Uptown Research Institute, LLC Chicago Illinois 60640 —
Alexian Brothers Center for Psychiatric Research Hoffman Estates Illinois 60169 —
Precise Research Centers Flowood Mississippi 39232 —
Millennium Psychiatric Associates, LLC Creve Coeur Missouri 63141 —
CRI Worldwide, LLC Willingboro New Jersey 08046 —
Windsor-Laurelwood Center for Behavioral Medicine Willoughby Ohio 44094 —
Vanderbilt Psychiatric Hospital Nashville Tennessee 37212 —
Claghorn-Lesem Research Clinic, Ltd. Houston Texas 77008 —
Pacific Institute of Medical Sciences Bothell Washington 98011 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 38 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01104766, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 29, 2018 · Synced Nov 11, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01104766 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →